BioWorld

June 10, 2009

View Archived Issues

Cancer Vaccine Firm 'Pique[s]' Investor Interest with Series A

Read More

CER called Game-Changer in Health Reform Debate

Read More

Tokai Prepares to Enter Clinic with Triple-Acting HRPC Drug

Read More

Corrections & Clarifications

Read More

Other News To Note

Read More

Clinic Roundup

Read More

ADA Roundup

Read More

MDRNA Wins FDA OK for Calcitonin in Osteo

MDRNA Inc. is making good on its plan to maximize its shelved nasal programs, with the FDA's approval of a generic nasal spray for osteoporosis that has been launched by Par Pharmaceutical Cos. Inc. (BioWorld Today) Read More